The global glycomics market is poised for significant growth, with its value estimated at USD 2.21 billion in 2024 and expected to rise to USD 2.53 billion by 2025. Over the next decade, the market is projected to reach approximately USD 8.66 billion by 2034, advancing at a robust CAGR of 14.64% from 2024 to 2034.
This growth is driven by the increasing applications of glycomics in critical areas such as drug discovery, disease diagnostics, therapeutics, and personalized medicine. The field’s ability to enhance understanding of glycan structures and their role in biological processes is fueling demand for glycomics tools and technologies.
Download statistics of this report @ https://www.towardshealthcare.com/download-statistics/5371
Glycomics studies the complex sugars (glycans) in biological systems and their roles in various biological processes. The field has advanced significantly due to new analytical tools, especially in areas like drug discovery, disease diagnosis, and personalized medicine.
Our Table of Content (TOC) covers key healthcare market segments, materials, technologies and trends—helping you navigate market shifts and make informed decisions: https://www.towardshealthcare.com/table-of-content/glycomics-market-sizing
Access exclusive insight now @ https://www.towardshealthcare.com/price/5371
We’ve prepared a service to support you. Please feel free to contact us at sales@towardshealthcare.com
Web: https://www.towardshealthcare.com
Visit Dental Specifics: https://www.towardsdental.com
Get the latest insights on industry segmentation with our Annual Membership: Get a Subscription
For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare
Azenta Life Sciences and Frenova, a division of Fresenius Medical Care and a leader in renal precision medicine, have announced… Read More
Zenara Pharma Private Limited, a leading Biophore company, has received final approval from the U.S. Food and Drug Administration (FDA)… Read More
Silexion Therapeutics Corp., a global clinical-stage biotech company specializing in RNA interference (RNAi) therapies, has announced outstanding new preclinical data… Read More
Canada and the UK have joined forces in a groundbreaking project aimed at developing next-generation immunotherapies for malignant melanoma, a… Read More
The liquid filtration for pharmaceutical market is rapidly evolving and is poised to generate hundreds of millions in revenue between… Read More
The global ophthalmology devices market is valued at USD 7.51 billion in 2024 and is projected to grow to USD… Read More